New Report Available: Philippines Pharmaceuticals & Healthcare Report Q1 2014
BMI is upgrading its generic drug market forecast on the back of greater acceptance of generic drugs coupled with progressive implementation of universal health coverage. As for the latter factor, we expect improvements in health-related infrastructure and the medical workforce in order to provide care for patients. The corresponding rise in the number of health facilities will spur demand for generic drugs and prescription drugs in general. Both factors will continue to provide opportunities for generic drug firms looking to...
View full press release